| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.4M | -29.6% |
| Cost of Revenue | $11.5M | -12.5% |
| Gross Profit | -$120K | -103.9% |
| R&D Expense | $386K | +191.1% |
| Operating Income | -$12.2M | -53.9% |
| Pre-tax Income | -$17.6M | -58.6% |
| Net Income | -$17.6M | -58.6% |
| EPS (Basic) | -$306.91 | -7955.4% |
| EPS (Diluted) | -$306.91 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $288K | -74.9% |
| Accounts Receivable | $1.2M | -56.2% |
| Inventory | $4.6M | -25.4% |
| Current Assets | $6.3M | -38.3% |
| Total Assets | $10.0M | -31.7% |
| Current Liabilities | $15.3M | +126.3% |
| Total Liabilities | $17.6M | +130.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | +0.3% |
| Capital Expenditures | $3K | -51.0% |
| Investing Cash Flow | -$3K | +99.1% |
| Financing Cash Flow | $6.2M | -23.6% |
| Free Cash Flow | -$7.0M | +0.3% |
| -7955.4% |
| Stockholders' Equity |
| -$7.6M |
| -209.1% |